Customized Registry Tool for Tracking Adherence to Clinical Guidelines for Head and Neck Cancers
NCT03546322 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 802
Last updated 2022-07-01
Summary
To implement and evaluate a health information technology platform designed to support the management of patients with head and neck cancer in an urban, publicly-funded outpatient setting. This is an observational study; researchers will not assign specific interventions to study participants.
Conditions
- Head and Neck Neoplasms
Interventions
- OTHER
-
Registry
Patients who are diagnosed with head and neck cancer and monitored by the Otolaryngology - Head and Neck Surgery clinic at Zuckerberg San Francisco General Hospital and Trauma Center will be included in this group. The intervention is the implementation of a registry, designed to replace existing paper-based systems for tracking patients. All head and neck cancer patients monitored by the clinic will be included.
Sponsors & Collaborators
-
Agency for Healthcare Research and Quality (AHRQ)
collaborator FED -
University of California, San Francisco
lead OTHER
Principal Investigators
-
Urmimala Sarkar, MD, MPH · University of California, San Francisco
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-06-01
- Primary Completion
- 2022-03-30
- Completion
- 2022-03-30
Countries
- United States
Study Locations
More Related Trials
-
TumorGraft- Guided Therapy for Improved Outcomes in Head and Neck Squamous Cell Cancer- A Feasibility Study
NCT02752932 ·Status: COMPLETED ·Phase: NA
-
Changes to Function and Quality of Life and Patient Experience for Patients Undergoing Treatments for Recurrent Oropharyngeal Cancer
NCT04952922 ·Status: COMPLETED
-
Head and Neck cancERs International cOviD-19 collabOraTion
NCT04632173 ·Status: UNKNOWN
-
Nasopharyngeal Carcinoma Post IMRT
NCT02597426 ·Status: ACTIVE_NOT_RECRUITING
-
Individualized Follow-Up for Head and Neck Cancer
NCT05386225 ·Status: RECRUITING
-
2 Phase Use Of Educational Materials In Head And Neck Cancer Center
NCT02204631 ·Status: COMPLETED ·Phase: NA
-
Health and Economic Outcomes of Two Different Follow up Strategies in Effectively Cured Advanced Head and Neck Cancer
NCT02262221 ·Status: SUSPENDED ·Phase: NA
-
Phase I Trial: T4 Immunotherapy of Head and Neck Cancer
NCT01818323 ·Status: RECRUITING ·Phase: PHASE1
-
Chemotherapy Followed by Surgery, Chemotherapy, and Radiation Therapy in Treating Patients With Locally Advanced Head And Neck Cancer
NCT00544414 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of the Implementation of Personalised Follow-up in Head and Neck Cancer
NCT06170203 ·Status: RECRUITING
-
Head and Neck Carcinoma Clinical Research Platform for Molecular and Blood-based Biomarkers, Treatment and Outcome
NCT06380686 ·Status: RECRUITING
-
Comparing Two Surveillance Approaches for People Who Have Received Treatment for HPV-associated Head and Neck Cancer and Show No Signs of Disease
NCT05048459 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Definitive Chemo-Radiotherapy for Regionally Advanced Head and Neck Cancer With or Without Up-front Neck Dissection
NCT02918955 ·Status: COMPLETED ·Phase: PHASE3
-
A Pilot Study of Induction Chemotherapy Followed by Surgery for Locally Advanced Resectable Head and Neck Cancer
NCT01111942 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
Multicenter Phase II Study of Sentinel Node Detection in Squamous Cell Carcinoma T1-T2N0 of the Oropharynx Treated With Radiotherapy and Larynx Treated by Surgery, Laser or Robot
NCT03010553 ·Status: UNKNOWN ·Phase: PHASE2
-
Ficlatuzumab w/wo Cetuximab in Patients w/Cetuximab-Resistant, Recurrent or Metastatic Head/Neck Squamous Cell Carcinoma
NCT03422536 ·Status: COMPLETED ·Phase: PHASE2
-
Access to Care Pilot for ED-Presenting Head and Neck Cancer Patients (ENRICH-HNC)
NCT07225725 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
A Phase II Study In Patients With Advanced Head And Neck Cancer Of Standard Chemoradiation And Add-On Cetuximab
NCT01435252 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Registry of Long-Term Dental Outcomes in Head and Neck Cancer Patients
NCT05325970 ·Status: ACTIVE_NOT_RECRUITING
-
Docetaxel + Cetuximab + Concurrent Re-Irradiation (Intensity - Modulated Radiation Therapy, IMRT) for Patients With Locoregionally Recurrent Head and Neck Cancer
NCT00713219 ·Status: COMPLETED ·Phase: PHASE2
-
Anti-tumor Specific Immune Response in Head and Neck Cancers
NCT02881918 ·Status: UNKNOWN
-
Validity and Reliability of Outcome Measures in Patients With Cancer of the Head and Neck
NCT01952821 ·Status: COMPLETED
-
Use of Computer-based Patient-reported Data to Assess Long Term and Late Effects of Head and Neck Cancer at the Point-of-care
NCT01803061 ·Status: COMPLETED ·Phase: NA
-
Study of Chemo-Immunotherapy in Head and Neck Cancer Patients
NCT01149902 ·Status: UNKNOWN ·Phase: PHASE1
-
Neoadjuvant Chemotherapy for Locally Advanced Squamous Cell Cancer of the Head and Neck (SCCHN)
NCT01312350 ·Status: COMPLETED ·Phase: PHASE2